Novartis, Bristol Myers join $72M funding for startup’s cancer radiotherapy R&D March 18, 2021 Auto Bot BioPharma, biopharma nl, Cambridge Massachusetts, cancer, Pharma, Startups 0 Aktis Oncology is developing cancer radiation treatments intended to more precise and potent compared to other radiotherapies. The startup is now out of stealth with $72 million in Series A financing.